Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
neurological disorders
Biotech
Insilico lands backloaded $2.5B AI deal with SK Biopharm
Under the potential $2.5 billion deal, Insilico and SK will develop AI-enabled drug candidates for neuroimmune disorders.
Angus Liu
Jun 22, 2026 12:30am
Biopharma R&D pipeline shrinks for 1st time in 30 years: report
Apr 3, 2026 8:13am
Alto halts work on PDE4 inhibitor after ph. 2 schizophrenia fail
Apr 2, 2026 7:17am
Neuro biotech Nido closes after 5 years
Jan 2, 2026 10:24am
Voyager jettisons staff, Novartis hands back 2 programs
Dec 17, 2025 4:50pm
Merck KGaA becomes latest partner for Flagship’s Valo Health
Nov 20, 2025 6:30am
